Jenburkt Pharma Live Share Price Today, Share Analysis and Chart

Name: Jenburkt Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Jenburkt Pharmaceuticals Ltd.
Rating: 2.411333375
Author: Trendlyne DVM scores

Mid-range Performer

about

Jenburkt Pharmaceuticals Ltd. is an established pharmaceutical company engaged in the manufacturing and marketing of specialty formulations. Celebrating 40 years of operation in 2025, the company focuses on therapeutic areas including pain management...

1137.70 14.20 (1.26%)

1,579

BSE Volume

BSE 05 Jun, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Medium Financial Strength

- / 100

Mid Valuation

- / 100

Technically Neutral

49.7 / 100

Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM

No estimates available

Jenburkt Pharma Live Price Chart

Loading Fundamental data..

Loading data..

Is Jenburkt Pharmaceuticals Ltd. worth buying?

29 Votes:

Buy 65.52%

Sell 20.69%

Hold 13.79%

Jenburkt Pharma Live Share Price Today, Share Analysis and Chart

Jenburkt Pharmaceuticals Ltd. is an established pharmaceutical company engaged in the manufacturing and marketing of specialty formulations. Celebrating 40 years of operation in 2025, the company focuses on therapeutic areas including pain management...

SWOT Analysis

Jenburkt Pharma Live Price Chart